Market Cap

Regeneron Pharmaceuticals, Inc. Market Capitalization:

$76.33 Billion

USD as of Jan. 1, 2025

business Regeneron Pharmaceuticals, Inc. Company Profile

Regeneron Pharmaceuticals, Inc. Main Stock Listing

NASDAQ: REGN

Market Capitalization History of Regeneron Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Marinomed Biotech AG $56.13 B
Samsung Biologics Co.,Ltd. $49.14 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Regeneron Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $76.33 B -23.67%
Jan. 1, 2024 $100.01 B 25.75%
Jan. 1, 2023 $79.53 B 19.00%
Jan. 1, 2022 $66.84 B 20.79%
Jan. 1, 2021 $55.33 B 49.09%
Jan. 1, 2020 $37.11 B -21.28%
Jan. 1, 2019 $47.14 B 17.08%
Jan. 1, 2018 $40.27 B 2.05%
Jan. 1, 2017 $39.46 B -14.47%
Jan. 1, 2016 $46.14 B 0.82%
Jan. 1, 2015 $45.76 B 44.38%
Jan. 1, 2014 $31.69 B 65.91%
Jan. 1, 2013 $19.10 B 91.44%
Jan. 1, 2012 $9.98 B 169.77%
Jan. 1, 2011 $3.70 B 26.33%
Jan. 1, 2010 $2.93 B 52.52%
Jan. 1, 2009 $1.92 B -13.81%
Jan. 1, 2008 $2.23 B 1.96%
Jan. 1, 2007 $2.18 B 30.60%
Jan. 1, 2006 $1.67 B 111.53%
Jan. 1, 2005 $790.7 M -51.55%
Jan. 1, 2004 $1.63 B -20.66%
Jan. 1, 2003 $2.06 B -24.48%
Jan. 1, 2002 $2.72 B -24.27%
Jan. 1, 2001 $3.60 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Company Description

Regeneron Pharmaceuticals, Inc. is a biotechnology company dedicated to molecules signaling, and targeted antibody drugs. Thanks to its patented treatments and technologies, Regeneron provides remedies for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases, and rare diseases.

business Regeneron Pharmaceuticals, Inc. Company Profile

Regeneron Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Regeneron Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: REGN

Stock: BMV: REGN

Stock: Bovespa: REGN34

Stock: FSX: RGO

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.